Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS.

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Reactive oxygen species (ROS) generated by NADPH oxidase type 2 (NOX2) are crucial for pathogen clearance and modulate immune responses, including T-cell suppression mediated by myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs).
• Excessive ROS in the tumor microenvironment can cause oxidative stress, potentially impairing anti-tumor immunity and leading to tumor toxicity.

Purpose of the Study:

• To investigate the role of NOX2-derived ROS in a methylcholanthrene (MCA)-induced sarcoma model.
• To determine if NOX2 functionality influences tumor incidence, immune cell infiltration, and response to therapy.

Main Methods:

• Utilized homozygous mutant mice (NCF1*/*) lacking superoxide burst and heterozygous mice (NCF1*/+) retaining this function.
• Induced sarcoma formation via intramuscular injection of MCA in NCF1 mutant mice.
• Conducted comprehensive immune monitoring, in vitro proliferation assays, and assessments of resistance to cisplatin and radiation therapy.

Main Results:

• NOX2 functionality did not affect tumor incidence in the MCA-induced sarcoma model.
• Infiltrating immune cells exhibited increased oxidative states in tumors, irrespective of NOX2 status.
• Accumulation of Tregs and MDSCs, along with increased effector-memory T cell markers, was observed in tumors from both NCF1 mutant groups.
• No significant differences were found in tumor proliferation or response to chemotherapy and radiation between NCF1*/* and NCF1*/+ mice.

Conclusions:

• NOX2 activity is not a critical determinant of tumor development or immune cell infiltration in the MCA-induced sarcoma model.
• The findings suggest that NOX2-derived ROS may not play a significant role in the immune response within this specific chemically induced tumor microenvironment.